Integrum ABOSTO:INTEG B +2.17%54 Gross Margin % is 61.47% as of Apr. 2026, which is 24% below its 10-year median of 80.42. GuruFocus rates OSTO:INTEG B with a GF Score™ of 54/100 and a GF Value™ of kr17.76 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 803 Medical Devices & Instruments companies, Integrum AB ranks better than 78.58% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Integrum AB's Gross Profit for the
three
months ended in Apr. 2026 was kr15.40 Mil. Integrum AB's Revenue for the
three
months ended in Apr. 2026 was kr25.06 Mil. Therefore, Integrum AB's Gross Margin % for the quarter that ended in Apr. 2026 was 61.47%.
Warning Sign:
Integrum AB gross margin has been in long-term decline. The average rate of decline per year is -2.1%.
The historical rank and industry rank for Integrum AB's Gross Margin % or its related term are showing as below:
OSTO:INTEG B'
s Gross Margin % Range Over the Past 10 Years
Min: 69.19 Med: 80.42 Max: 87.65
Current: 69.19
During the past 12 years, the highestGross Margin % of Integrum AB was 87.65%. The lowest was 69.19%. And the median was 80.42%.
OSTO:INTEG B's Gross Margin % is ranked better than 78.58% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs OSTO:INTEG B: 69.19
Integrum AB had a gross margin of 61.47% for the quarter that ended in Apr. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Integrum AB was -2.10% per year.
Integrum AB (OSTO:INTEG B) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Integrum AB had a gross margin of 61.47% for the quarter that ended in Apr. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Integrum AB Gross Margin % Related Terms
Integrum AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for Integrum AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:INTEG B vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Integrum AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrum AB Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Integrum AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Integrum AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Integrum AB (OSTO:INTEG B) has a Gross Margin % of 61.47% as of Apr. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Integrum AB and its competitors. This is 24% below median its historical median of 80.42. Over the past decade, Integrum AB's Gross Margin % has ranged from 69.19 to 87.65. According to the industry distribution chart, Integrum AB ranks #172 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 21.4%.
Is Integrum AB's Gross Margin % too high?
Integrum AB's current Gross Margin % of 61.47% is 24% below median its 10-year median of 80.42. Over the past 10 years, this metric has ranged from a low of 69.19 to a high of 87.65. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Integrum AB's value of 61.47% is 18.1% above this industry median. Based on the distribution chart, Integrum AB ranks #172 out of 803 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Integrum AB has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Integrum AB ranks #172 out of 803 companies for Gross Margin %. This places Integrum AB in the top 21% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.03. Integrum AB's value of 61.47% is 18.1% above this benchmark. Historically, Integrum AB's own Gross Margin % has ranged from 69.19 to 87.65 over the past decade. While the company's 10-year median is 80.42 vs. the industry median of 52.03, Integrum AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrum AB's current Gross Margin % of 61.47% is 18.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Integrum AB and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrum AB's current Gross Margin % is 61.47%, which is 24% below median its own 10-year median of 80.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (OSTO:INTEG B) is currently considered Possible Value Trap. The stock's GF Value™ is kr17.76, compared to a current price of kr8.49 — trading 52.2% below its estimated fair value. The current Gross Margin % is 61.47%, which is 24% below median its 10-year median of 80.42 and 18.1% above the Medical Devices & Instruments industry median of 52.03. Integrum AB's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Integrum AB (OSTO:INTEG B), the current Gross Margin % is 61.47% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrum AB (OSTO:INTEG B) Overvalued in 2026?
Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued.
The current stock price of kr8.49 is trading 52.2% below its estimated GF Value™ of kr17.76.
GuruFocus considers Integrum AB to be Possible Value Trap.
Key valuation signals for OSTO:INTEG B:
Gross Margin %: 61.47% (24% below median its 10-year median of 80.42)
GF Value™: kr17.76 vs. price of kr8.49 (52.2% below fair value)
Industry Position: 18.1% above the Medical Devices & Instruments median (#172 of 803)
No single metric tells the full story. See the OSTO:INTEG B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
54GF Score
Get the complete analysis for OSTO:INTEG B
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:INTEG B has been successfully added to your 
